New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Novozymes and Chr. Hansen introduce first joint product

Milwaukee, Wisconsin – Three years ago, Novozymes and Chr. Hansen formed a strategic alliance, and now the research and development pays off. The first product from the alliance is ready and is introduced this week. The two companies have applied for a joint patent for YieldMAX™ PL – an advanced enzyme solution tailor made for mozzarella and pizza cheese. This is of particular interest to the large United States market.

“Under normal conditions, YieldMAX™ PL will increase production yield by approximately two percent. This may not seem like very much to the untrained eye, but it is in fact a good result,” says R&D Director Steffen Ernst from Novozymes. “In comparison, it is estimated that the combined efforts of the entire dairy industry has increased yield by just one percent over the last decade.”

The two equal partners in the alliance have high hopes for YieldMAX™ PL. The top ten US dairies alone produce an estimated one million metric tons of mozzarella and pizza cheese each year, and just two percent of that amounts to 44 million pounds of cheese. The potential for the new enzyme could be quite large.

The perfect partnership
The alliance between Chr. Hansen and Novozymes combines the unique technologies and know-how of the two companies. In this way, they strengthen and complement each other's value chains and become a strong partner for the dairy industry worldwide. In general, Novozymes contributes with expertise in research, development, and production of the new enzymes, while Chr. Hansen is responsible for sales, marketing, and technical support to customers.

“Novozymes is a world class expert in enzyme development and production, and Chr. Hansen has for more than 130 years worked with the food industry on enzyme solutions,” says Knud Vindfeldt, Executive Vice President for Cultures and Enzymes at Chr. Hansen. “Together, our two companies can achieve results that would never be possible alone.”

YieldMAX™ PL is just the first revolutionary enzyme solution from Chr. Hansen and Novozymes. In the coming years, the alliance will continue to work on launching more new enzyme solutions, including solutions that increase yield, or improve texture or taste in dairy products.

YieldMAX™ PL is officially presented to the public this week at the World Wide Food Expo in Chicago, USA.

Operating from facilities in thirty countries worldwide, Chr. Hansen is a global biotechnology company that provides ingredients to the food, dairy, human health and nutrition, and animal health industries. Based on intensive research, Chr. Hansen works to improve the quality of food and health for people all over the world. The company is a primary supplier of cultures, probiotics, enzymes, colors, flavors, seasonings, sweeteners, and tablet coatings and excipients, which are applied in foods and beverages, pharmaceuticals, dietary supplements, and agricultural products. For more information, visit

# # #

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.